Northrop Grumman (NOC) Form 4 NORTHROP GRUMMAN / Kenneth B. Crews ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Crews Kenneth B.

(Last) (First) (Middle)

2980 FAIRVIEW PARK DRIVE

(Street)

FALLS CHURCH VA 22042

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NORTHROP GRUMMAN CORP /DE/ [ NOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
CVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2025		M		593.85	A	$0	2,659.68	D
Common Stock	02/18/2025		F		184	D	$441.36	2,475.68	D
Common Stock	02/18/2025		M		253	A	$0	2,728.68	D
Common Stock	02/18/2025		F		84	D	$441.36	2,644.68	D
Common Stock								84.4492	I	Held in the Northrop Grumman Savings Excess Plan(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Performance Stock Rights	(2)	02/18/2025		A		4,628.85(3)		(2)	(2)	Common Stock	4,628.85	$0	9,151.85(4)	D
Restricted Stock Rights	(5)	02/18/2025		A		2,105		(5)	(6)	Common Stock	2,105	$0	4,136(7)	D
Restricted Performance Stock Rights	(2)	02/18/2025		M			593.85	(2)	(2)	Common Stock	593.85	$0	8,558(8)	D
Restricted Stock Rights	(5)	02/18/2025		M			253	(5)	(9)	Common Stock	253	$0	3,883	D

Explanation of Responses:

1. Held in the Northrop Grumman Savings Excess Plan (the "Plan"), as of February 18, 2025. Share totals with respect to the Plan are based upon unit accounting and therefore may reflect a change in units attributable to an individual though no acquisition or disposition occurred.

2. Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).

3. The RPSRs acquired include (i) 38.85 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 4,590 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 593.85 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 555 RPSRs was previously reported in connection with the grant of the 2022 RPSRs.

4. Total amount includes (i) 593.85 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 542 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 627 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iv) 2,799 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (v) 4,590 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

5. Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

6. The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028.

7. Total amount includes (i) 253 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 232 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 269 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (iv) 1,277 RSRs granted under the 2024 LTISP on 7/31/24 that will vest on 8/2/2027; and (v) 2,105 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28.

8. Total amount includes (i) 542 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 627 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iii) 2,799 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (iv) 4,590 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.

9. Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25.

Remarks:

	/s/ Jennifer C. McGarey, Attorney-in-Fact	02/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.